Predictors of Clinical Improvement, Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
- 1 October 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 30 (10) , 2094-2100
- https://doi.org/10.1161/01.str.30.10.2094
Abstract
Background and Purpose—We sought to evaluate predictors of clinical outcome, angiographic success, and adverse effects after intra-arterial administration of urokinase for acute ischemic stroke. Me...Keywords
This publication has 10 references indexed in Scilit:
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)Published by Elsevier ,1998
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric StrokeJAMA, 1995
- Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA)Neuroradiology, 1993
- Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeAnnals of Neurology, 1992
- Intravenous recombinant tissue plasminogen activator in acute carotid artery territory strokeNeurology, 1992
- Clinical and instrumental evaluation of patients with ischemic stroke within the first six hoursJournal of the Neurological Sciences, 1989
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Functional recovery of cortical neurons as related to degree and duration of ischemiaAnnals of Neurology, 1983
- Cerebral Vascular Accidents in Patients over the Age of 60: II. PrognosisScottish Medical Journal, 1957